Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Standards
|
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
2 |
Material Type: Standards
|
Ponesimod for treating relapsing–remitting multiple sclerosisNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
3 |
Material Type: Standards
|
Givosiran for treating acute hepatic porphyriaNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
4 |
Material Type: Standards
|
Romosozumab for treating severe osteoporosisNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
5 |
Material Type: Standards
|
Ovarian cancer: identifying and managing familial and genetic riskNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
6 |
Material Type: Standards
|
Fetal alcohol spectrum disorderNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
7 |
Material Type: Standards
|
Caesarean birthNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
8 |
Material Type: Standards
|
Abortion careNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
9 |
Material Type: Standards
|
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
10 |
Material Type: Standards
|
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
11 |
Material Type: Standards
|
Abortion careNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
12 |
Material Type: Standards
|
Antenatal careNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
13 |
Material Type: Standards
|
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
14 |
Material Type: Standards
|
Intrapartum care: existing medical conditions and obstetric complicationsNICE Guidance, 2020Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
15 |
Material Type: Standards
|
Heart valve disease presenting in adults: investigation and managementNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
16 |
Material Type: Standards
|
Postnatal careNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
17 |
Material Type: Standards
|
Pelvic floor dysfunction: prevention and non-surgical managementNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
18 |
Material Type: Standards
|
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumabNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
19 |
Material Type: Standards
|
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
20 |
Material Type: Standards
|
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |